Ventas (VTR) Projected to Release Quarterly Earnings on Wednesday

Ventas (NYSE:VTR) is projected to post its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect Ventas to post earnings of $0.1423 per share and revenue of $1.6808 billion for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the business earned $0.84 earnings per share. The company’s revenue for the quarter was up 22.0% on a year-over-year basis. On average, analysts expect Ventas to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Ventas Trading Up 0.1%

Shares of Ventas stock opened at $100.61 on Monday. Ventas has a 1 year low of $65.15 and a 1 year high of $100.84. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The business has a 50 day moving average price of $88.17 and a 200 day moving average price of $84.91. The company has a market capitalization of $48.92 billion, a P/E ratio of 182.94, a P/E/G ratio of 2.16 and a beta of 0.70.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.1%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Insider Buying and Selling at Ventas

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas

Large investors have recently added to or reduced their stakes in the business. State Street Corp boosted its stake in Ventas by 2.5% in the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after buying an additional 735,620 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Ventas by 27.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock valued at $710,060,000 after acquiring an additional 2,000,341 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Ventas by 5.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,937,575 shares of the real estate investment trust’s stock valued at $536,853,000 after acquiring an additional 336,432 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Ventas by 1.7% during the 3rd quarter. Northern Trust Corp now owns 6,402,941 shares of the real estate investment trust’s stock worth $448,142,000 after acquiring an additional 108,990 shares during the period. Finally, Morgan Stanley lifted its holdings in shares of Ventas by 19.9% during the 4th quarter. Morgan Stanley now owns 6,344,347 shares of the real estate investment trust’s stock worth $490,926,000 after acquiring an additional 1,051,836 shares during the period. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Evercore reissued an “outperform” rating and issued a $95.00 price target on shares of Ventas in a report on Wednesday, April 29th. Royal Bank Of Canada increased their price objective on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Jefferies Financial Group lifted their price objective on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. BMO Capital Markets reissued an “outperform” rating and issued a $100.00 target price on shares of Ventas in a research note on Monday, May 4th. Finally, Citigroup upped their target price on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a report on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $96.50.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.